Facultad de Ciencias del Deporte
San Javier, Murcia, 30720, Spain
Location status: Recruiting
Location contact
Jesus Garcia Pallares, PhD
CONTACT
Jesus Garcia Pallares, PhD
SUB_INVESTIGATOR
NCT Number: NCT07426172
The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
San Javier, Murcia, 30720, Spain
Location status: Recruiting
Jesus Garcia Pallares, PhD
CONTACT
Jesus Garcia Pallares, PhD
SUB_INVESTIGATOR
Individuals with metabolic syndrome and insulin resistance exhibit higher resting lactate concentrations than age-matched counterparts without metabolic disease. Recent studies suggest that lactate is not just a by-product of accelerated glycolysis but a signaling molecule that could even affect gene expression. However, the role of lactate in carbohydrate and fat metabolism at rest and during exercise remains incompletely described.
In this study, the investigators will elevate blood lactate levels in metabolically healthy individuals to levels observed in individuals with metabolic syndrome while measuring fat and carbohydrate metabolism in a fasted state, during exercise, and in response to an oral glucose load (oral glucose tolerance test).
10 metabolically healthy (MH) and 10 metabolically impaired (MI) individuals matched for sex and physical activity will participate in the study. MH will undergo two trials: one with intravenous lactate infusion and the other with isovolumetric saline infusion. The MI group will undergo only the saline trial.
Each trial consists of a 150 min basal period, an exercise period, followed by a 2-hour oral glucose tolerance test (OGTT). During the test, the investigators will:
Measure insulin sensitivity during the OGTT (Matsuda Index). Measure fat and carbohydrate oxidation using indirect calorimetry. Use stable isotope infusion to measure glycerol and glucose turnover rates in plasma using [1,1,2,3,3 2H]-glycerol and [6-6 2H], [U, 13C] - glucose.
Collect blood samples of relevant hormones, metabolites, and cytokines.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Raise blood lactate in metabolically healthy individuals to the levels of individuals with metabolic syndrome
Saline infusion as a control treatment
Time frame: through study completion, an average of 2 years
Change in plasma [1,1,2,3,3 D] glycerol turnover rates
Time frame: through study completion, an average of 2 years
Change in plasma [6,6 D]-glucose turnover rate
Time frame: through study completion, an average of 2 years
The difference between groups and interventions in Matsuda ISI during the glucose tolerance test
Time frame: through study completion, an average of 2 years
Changes in fat and carbohydrate oxidation during treatments in both groups.
Time frame: through study completion, an average of 2 years
Insulin concentrations. Difference between interventions and groups
Time frame: through study completion, an average of 2 years
Glucose concentrations. Difference between interventions and groups
Time frame: through study completion, an average of 2 years
Free fatty acids concentration. Difference between interventions and groups
Time frame: through study completion, an average of 2 years
Glycerol concentrations. Difference between interventions and groups
Time frame: through study completion, an average of 2 years
lactate concentrations. Difference between interventions and groups
Time frame: through study completion, an average of 2 years
Tracer/tracee ratio measured by CGMS of 13C/12C glucose
Time frame: through study completion, an average of 2 years
Analisys of 13CO2 / 12CO2 by IRMS
Time frame: through study completion, an average of 2 years
Ratio of plasma D2 glucose / unlabeled glucose measured by GCMS
Time frame: through study completion, an average of 2 years
Blood ratio of D5 glycerol / unlabeled glycerol measured with GCMS
Contact information is provided by the study sponsor or research team.
Jesus Garcia-Pallares, PhD
CONTACT
Ricardo MORA RODRIGUEZ, PhD
CONTACT
Ricardo Mora
Other
Acronym: LACTMET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07702487
Hyperlactatemia, Intraoperative Hypothermia
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT05032521
Actue Circulatory Failure, Hyperlactatemia
Dijon, France
View Trial DetailsNCT05505396
Acute Brain Injury, Brain Diseases
Copenhagen, Denmark
View Trial DetailsNCT04046861
Bypass Complication, Cardiac Disease
Maribor, Slovenia
View Trial Details